Gelonghui April 25 | Olin Biotech (688319.SH) announced its 2023 annual report. The company achieved revenue of 496 million yuan in 2023, a year-on-year decrease of 9.38%; net profit attributable to the parent company was 17.56 million yuan, a year-on-year decrease of 33.94%; Non-net profit after deducting was 3.39 million yuan, a year-on-year increase of 370.1%; basic earnings per share was 0.0433 yuan. The company plans to distribute a cash dividend of 0.38 yuan (tax included) for every 10 shares.
Gelonghui April 25 | Olin Biotech (688319.SH) announced its 2023 annual report. The company achieved revenue of 496 million yuan in 2023, a year-on-year decrease of 9.38%; net profit attributable to the parent company was 17.56 million yuan, a year-on-year decrease of 33.94%; Non-net profit after deducting was 3.39 million yuan, a year-on-year increase of 370.1%; basic earnings per share was 0.0433 yuan.
The company plans to distribute a cash dividend of 0.38 yuan (tax included) for every 10 shares.
